FMR1 and fragile X syndrome: With respect to identifying compounds that can reactivate the FMR1 gene in FXS cells, HTS can help identify new biologically active small molecules against known targets, for example, DNA methyltransferases, histone deacetylases, and histone methyltransferases, as well as identify additional targets that might provide new insights into the gene silencing mechanism.